The LP Advisory Committee (LPAC) in Private Equity Funds

The LP advisory committee (LPAC) is a governance body that represents limited partners’ interests within a private equity fund. It has no power to control investment decisions but can block or approve certain GP actions—particularly conflicts of interest, related-party transactions, fund valuations, and amendments to key terms.

Why the LPAC exists

Large pools of capital in private equity create an inherent conflict: the GP earns fees regardless of performance, and may be tempted to approve self-dealing transactions, change fund terms quietly, or overvalue holdings to support fee calculations or co-investment opportunities. The LPAC is a lightweight governance layer designed to catch these risks without second-guessing the GP’s core investment strategy.

The LP advisory committee is particularly common in funds above $500M—small enough that no single LP can force disclosure, large enough that coordination among dozens of LPs would be impractical. It essentially gives a rotating group of committed LPs a seat at the table.

Composition and election

An LPAC typically has 3–5 members, drawn from the fund’s LP base and elected by majority vote among all LPs based on capital commitment. Larger LPs often hold seats; fund documents may require regional or sector diversity. Some committees include a GP representative (non-voting), which improves information flow but can create awkwardness if a vote goes against the GP.

The chairperson usually rotates annually, giving multiple LPs experience with the fund’s operations and relationships. In practice, the role attracts institutional LPs—university endowments, pension funds, insurance companies—who have the staff to engage meaningfully. Retail LPs through funds of funds may delegate their vote to the fund-of-funds manager.

Membership carries no explicit compensation; the fund pays meeting and travel costs. Some LPs view LPAC participation as a due-diligence advantage (direct access to the GP), while others see it as a governance responsibility. Frequent turnover is rare—most appointed LPs serve for several years.

Approval powers: what the LPAC actually controls

The LPAC’s core function is approving specific categories of transactions and disclosures:

Conflicts of interest and related-party transactions. If the GP wants to pay affiliate fees, hire a portfolio company to a related service provider, or seed a new fund from existing portfolio holdings, the LPAC typically must approve. The standard is “fair to the fund”—meaning the LPAC can reject an unfair deal or demand a price adjustment.

Valuations and their disputes. The GP values holdings quarterly. If an LP disagrees or challenges a valuation, or if an independent valuation service contradicts the GP’s mark, the LPAC often acts as mediator or decision-maker. This is especially important for illiquid holdings where no market price exists.

Amendments to key fund terms. Changing the fee structure, extending the fund’s life, altering distribution waterfalls, or modifying LP withdrawal rights usually requires LPAC consent (sometimes alongside a supermajority LP vote).

Removal of the GP. In rare cases of fraud or material breach, the LPAC may recommend (and sometimes force) removal. This power is rarely used—if the GP is acting fraudulently, LPs pursue litigation.

Waivers of fees or side letters. If the GP wants to charge discounted fees to a new anchor LP or waive a clause for a preferred investor, LPAC approval ensures no unfair preference.

What the LPAC cannot do

The LPAC is explicitly NOT an investment committee. It cannot:

• Veto or approve individual investments or exits
• Force the GP to deploy capital faster or slower
• Override return calculations or dividend distributions
• Hire or fire the GP’s team (except in egregious breach)
• Micromanage portfolio company operations
• Unilaterally change the fund’s strategy

This boundary is crucial—the whole point is for the GP to have discretionary power to invest and operate, while the LPAC polices conflicts and governance.

Typical LPAC agenda

Quarterly meetings commonly cover:

1. Valuation review. Each holding’s mark and supporting rationale; any changes quarter-over-quarter.
2. Conflict review. Any proposed related-party transactions, side agreements, or fee waivers.
3. Fund performance. Net return, IRR, capital deployed, and J-curve progress.
4. Regulatory and audit items. Independent auditor observations, tax position changes, ERISA or other compliance updates.
5. Portfolio updates. Major portfolio company changes, exits in progress, or restructurings.
6. Amendments or term waivers. Requests for GP approval that also require LPAC sign-off.

Meetings are usually closed to the broader LP base—LPAC members sign NDAs covering portfolio details. Minutes are distributed to all LPs (heavily redacted) or held as confidential, depending on fund documents.

How conflicts actually get resolved

The LPAC’s teeth come from transparency and delay. If a GP proposes a conflicted transaction, it must disclose to the LPAC first. The LPAC then votes to approve, reject, or demand modifications. If the LPAC rejects an action without sufficient LP support, the GP cannot proceed.

In practice, most conflicts are negotiated: the GP proposes, the LPAC questions, and they reach a middle ground—a lower fee, a clawback clause, or an independent fairness opinion.

If the LPAC and GP are at permanent loggerheads, the relationship has failed. LPs would then consider triggering a GP removal clause or switching to a new fund—which is expensive and rare, making LPAC restraint in the interest of both sides.

Self-dealing and the LPAC’s limits

One enduring tension: the LPAC is made up of LPs, some of whom may have conflicts of their own. An LP on the LPAC who also co-invests alongside the GP is less likely to scrutinize the GP’s co-investment terms closely. Fund documents try to address this by requiring recusal—a conflicted LPAC member steps out of votes affecting that member.

Also, the LPAC is reactive, not proactive. It can block or demand fairness, but it relies on the GP’s voluntary disclosure. LPs hired independent advisors to audit fund operations for this reason.

Effectiveness and common issues

Large LPs view LPAC participation as a check on GP power—a way to ensure that fee waivers, valuation disputes, and related-party deals don’t go unscrutinized. Smaller LPs benefit indirectly, knowing that committed LPs are paying attention.

Common frictions arise when:

• Valuations are disputed. A portfolio company is down; the GP wants to carry it at cost; the LPAC suspects it’s worth less. This can delay quarter-end reporting.
• GP co-investments rise. If the GP is increasingly co-investing its own capital (or affiliate capital) in deals alongside the fund, the LPAC may feel less alignment.
• Fee structures shift. The GP may try to transition to higher carried interest or new fee buckets, triggering LPAC and full LP votes.
• Fund extensions are proposed. As a fund nears its expiration, the GP may seek a multi-year extension—a term change the LPAC must approve, and some LPs oppose.

The LPAC in the broader fund governance picture

The LPAC is one layer in a multi-stakeholder governance structure. Above it sits the GP (which sets strategy) and below sit the portfolio companies (which operate independently). Alongside sit the independent auditor, the fund’s custodian and administrator, and the broader LP base (who can call a meeting to demand answers).

The LPAC’s real value lies in early warning. If valuations are consistently high, related-party fees are climbing, or conflicts are unresolved, an active LPAC surfaces these issues before they become crises. It is not a rubber stamp and not a board of directors—it is a committed minority of LPs with escalation power.

See also